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Abstract 
Objectives: Although clinical evidence suggests important differences between unipolar 
mania and bipolar-I disorder (BP-I), epidemiological data are limited. Combining data from 9 
population-based studies, we compared subjects with mania (M) or mania with mild 
depression (Md) to those with BP-I with both manic and depressive episodes with respect to 
demographic and clinical characteristics in order to highlight differences.  
Methods: Participants were compared for gender, age, age at onset of mania, psychiatric 
comorbidity, temperament and family history of mental disorders. Generalized Linear Mixed 
Models with adjustment for sex and age as well as for each study source were applied. 
Analyses were performed for the pooled adult and adolescent samples, separately. 
Results: Within the included cohorts, 109 adults and 195 adolescents were diagnosed with 
M/Md and 323 adults and 182 adolescents with BP-I. In both adult and adolescent samples, 
there was a male preponderance in M/Md, whereas lifetime generalized anxiety and/panic 
disorders and suicide attempts were less common in M/Md than in BP-I. Furthermore, adults 
with mania revealed bulimia/binge eating and drug use disorders less frequently than those 
with BP-I.  
Conclusions: The significant differences found in gender and comorbidity between mania 
and BP-I suggest that unipolar mania, despite its low prevalence, should be established as a 
separate diagnosis both for clinical and research purposes. In clinical settings, the rarer 
occurrence of suicide attempts, anxiety and drug use disorders among individuals with 
unipolar mania may facilitate successful treatment of the disorder and lead to a more 
favorable course than that of BP-I disorder. 
 
Key words: Mania; Bipolar-I disorder; Epidemiology; Gender; Comorbidity, family 
history 
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1. Introduction 
The affective spectrum as conceptualized by Akiskal (1) originally comprised depression, 
bipolar-II and bipolar-I disorders. It was later extended to include mania with mild depression 
(Md) and pure mania (M) as separate diagnostic subgroups (2). The international diagnostic 
manuals, however, do not reflect the full affective spectrum. Mania – in contrast to 
depression – does not currently have the status of a separate disorder. Although the 
international classification of diseases of 1978 (ICD-9) (3) provided a separate coding 296.0 
for monopolar mania, since ICD-10 (1993) (4) a manic episode has only been codable within 
mood disorders (F30). Similarly in successive editions of the diagnostic and statistical 
manual, DSM-III (1980) (5), DSM-IV-TR (2000) (6) and DSM-5 (2013) (7), a single manic 
episode (296.0) is coded within bipolar-I (BP-I) disorder. 
From a clinical perspective, there is strong evidence that some patients suffer from pure 
unipolar mania or mania with mild (not major) depression although it is relatively rare. 
Notable differences between unipolar mania and BP-I disorder have been reported in 
literature reviews and single studies on mania (8-11), including a more frequent premorbid 
hyperthymic temperament (8-10), less suicidality (8, 10-13), a lower likelihood of developing 
comorbid anxiety disorders (8-10, 12), more psychotic features and more cannabis abuse 
(12) for subjects with unipolar mania. In addition, with some exceptions (14), there is 
evidence that individuals with pure mania are less likely to have a positive family history for 
major depressive disorder (MDD) (15) and family studies have found evidence for 
independent familial aggregation of manic and depressive episodes (16, 17).  
Although evidence from population samples has been limited owing to the relative 
infrequency of M/Md, the first large-scale study of unipolar mania in adults in the community 
based on the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC) 
found a prevalence of unipolar mania of approximately 0.2% and significant differences 
between mania and bipolar in a range of demographic and clinical characteristics (18). Those 
with mania were more likely to be male and non-white, to have an earlier age at onset of 
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manic episodes, to experience shorter episodes and to have a lower lifetime comorbidity with 
Generalized Anxiety Disorder (GAD), panic disorder and social and specific phobia. The 
authors concluded that unipolar mania is an infrequent but clinically distinct valid subtype of 
bipolar disorder (18). 
Aims of the study: 
Our analysis sought to provide further evidence for the independence of unipolar mania from 
BP-I disorder with both manic and depressive episodes. In order to overcome the problem of 
limited sample size related to the low prevalence of unipolar mania, we pooled data from 
nine community studies in five countries to compare mania with or without mild depression 
and BP-I disorder with respect to sociodemographic and clinical characteristics, comorbid 
disorders, temperamental features and family history in order to highlight differences. 
 
2. Material and methods 
2.1. Community samples and diagnoses 
The data, which were collected through semi-structured or structured interviews, unbiased by 
the hypothesis of this paper, derived from the following nine epidemiological studies:  
1) The Zurich Study, conducted in the Canton of Zurich, used a stratified sample enriched by 
risk cases (N=591 representing weighted 2600 subjects). The sample was screened in 1978 
at age 19 (males) or 20 (females) and interviewed 7 times (1979–2008) until the probands 
were 49/50 years old. The interviews, administered by psychiatrists and psychologists, were 
based on the Structured Psychopathological Interview and Rating of the Social 
Consequences of Psychological Disturbances for Epidemiology (SPIKE) (19). Major 
depressive episodes were diagnosed according to DSM-IV/DSM-5 criteria and mania 
according to modified DSM-5 criteria (i.e. criterion A modified: presence of increased 
activity/energy or elated mood or irritable mood required). All other diagnoses were based on 
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the DSM-IV. Temperament was assessed by the General Behavior Inventory (20) and by 
direct SPIKE interview questions. 
2) The ZInEP Epidemiology Survey, designed in congruence with the Zurich Study, was 
carried out between August 2010 and September 2012 (21). A representative sample of 
9829 participants living in the canton of Zurich was screened by a Computer Assisted 
Telephone Interview (CATI) using the Symptom Checklist-27 (SCL-27) (22). A total of 1500 
participants were selected from this sample following a stratified sampling procedure, which 
included 60% high-scorers and 40% low-scorers (the cut-off criterion being the 75th percentile 
of the Global Severity Index of the SCL-27). The subsamples corresponded exactly in age to 
the assessment points of the Zurich Study from 1979 (20 years) to 1999 (40 years). They 
were interviewed by extensively trained psychologists using a shortened version of the 
SPIKE (19). Diagnoses of common mental disorders were computed as 12-month 
prevalence rates based on DSM-IV criteria. In mania / hypomania and bipolar disorders, the 
criteria of the Bridge Study were adopted (23). This definition includes not only elated or 
irritable mood in criterion A, but also increased activity/energy and tentatively shortens the 
minimum duration of a hypomanic episode from four days to one day. It also eliminates all 
the exclusion criteria. 
3) São Paulo Megacity Mental Health Survey is a cross-sectional household population-
based survey conducted in the São Paulo Metropolitan Area (SPMA, the city of São Paulo 
and its 38 surrounding municipalities), Brazil. At the time of data collection (2005–2007), 
around 11 million inhabitants aged 18 years or older lived in the SPMA, from which a 
representative stratified multistage area probability sample of 5037 respondents was 
selected. Respondents were assessed by trained professional lay interviewers using the 
World Mental Health Survey Composite International Diagnostic Interview (CIDI 3.0), a fully 
structured lay interview that generates diagnoses according to the DSM-IV criteria, translated 
and adapted to the Brazilian-Portuguese language. Weights were applied to adjust for 
differences in the probability of selection, differential non-response, and post-stratifying the 
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final sample to approximate the year 2000 population census regarding gender and age 
distribution. The overall response rate was 81.3%. Further details regarding the methodology 
have been published elsewhere (24). 
4) Pelotas Study: N=1560 is a cross-sectional population-based study including subjects 18 
to 24 years old living in the urban area of Pelotas (Brazil). The sample selection was 
performed by clusters considering the population of 39 667 in the age range according to the 
current census of 448 sectors in the city (www.ibge.gov.br). In order to ensure the necessary 
sample size, 89 census-based sectors were randomly selected. The home selection in the 
sectors was performed according to a systematic sampling, the first one being the house at 
the corner pre-established by the Brazilian Geographical and Statistical Institute (IBGE) as 
the beginning of the sector; the interval of selection was determined by skipping two houses. 
Respondents were assessed by trained undergraduate students in the field of health 
sciences using the Mini International Neuropsychiatric Interview (MINI), a structured clinical 
interview according to DSM-IV criteria. Further details regarding the methodology have been 
published elsewhere (25). 
5) The National Comorbidity Survey Replication (NCS-R) is a national study of English 
speakers of the conterminous United States. Part I comprised subjects aged 18 to 44 
(N=5692). The interviews were conducted by trained lay interviewers. Diagnoses were made 
according to the DSM-IV based on a WHO modified version of the Composite International 
Diagnostic Interview (CIDI) (26). 
6) The prospective CoLaus¦PsyCoLaus Study (27, 28) included 4874 35 to 84-year-old 
subjects, (46.5% male, mean age = 11.2 s.d. 35.8 years), who were recruited from the 
general population of the City of Lausanne according to the civil register. Subjects were 
interviewed by trained master’s level psychologists using the Diagnostic Interview for Genetic 
Studies (DIGS) (29); psychiatric disorders as well as mood episodes were diagnosed 
according to DSM-IV criteria. The diagnosis of hyperthymic temperament was assigned 
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according to the criteria of Gershon et al. (30), which required periods of elation or 
excitement lasting most of the time (chronic form) and resulted in: 1) the subject 
communicated with a close friend or relative on how he/she felt, or 2) someone complained 
or commented on some manifestation of this condition. Family history information was based 
on the Family History-Research Diagnostic Criteria (FH-RDC, (31); validity of the French 
version (e.g. (32)). 
7) The Netherlands Study of Depression and Anxiety (NESDA) is a longitudinal naturalistic 
cohort study, consisting of 2981 persons (18–65 years) including those with lifetime anxiety 
and/or depressive disorders (n=2329; 78%), as well as healthy controls (n=652; 22%) (33). 
Participants were recruited from the community (n=564; 19%), primary care settings 
(n=1610; 54%) and specialized mental health care (n=807; 27%) from September 2004 to 
February 2007 at three study sites (Amsterdam, Groningen, Leiden). Exclusion criteria used 
at baseline were (1) clinically overt diagnoses of other psychiatric conditions, such as 
psychotic, obsessive compulsive, bipolar, or severe addiction disorder, and (2) not being 
fluent in Dutch.  
The NESDA subsample comprised those probands who at 2-year follow-up had developed 
bipolar disorder. A total of 2596 persons (87.1%) participated in the 2-year follow-up 
interview, conducted by well-trained research staff often with a medical or psychology 
background, during which mania and bipolar-I were assessed. Determinants of loss to follow-
up were younger age, less years of education, not being of North-European descent, being 
recruited in Amsterdam, no previous participation in research and having major depressive 
disorder (34). 
The CIDI (v2.1) was used to assess the presence and age at onset of DSM-IV diagnoses of 
depression, anxiety, alcohol abuse/dependence (35). At the 2-year follow-up, the CIDI also 
included the mania section from which lifetime diagnoses were derived. Suicidality was 
assessed using a question that was added to the interview: 'Have you ever made a serious 
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attempt to end your life, for instance by harming or poisoning yourself or by getting into an 
accident?' . Family history in first degree relatives was assessed using the Family Tree 
Inventory (36). 
8) The Early Developmental Stages of Psychopathology (EDSP) study conducted in 
Munich, Germany, used an age stratified random community sample (N=3021, 
response: 71%) followed up in 3 waves over 10 years (37). Adolescents and young 
adults, aged 14 to 24 years at study intake, participated partly with their parents and 
selected family members. Interviews, which were conducted by trained interviewers 
(clinical and non-clinical), were based on the DSM-IV/M-CIDI and family history methods on 
parental psychopathology were also used (38). 
 
9) The National Comorbidity Survey Replication-Adolescent Supplement (NCS-A) used 
representative household and school samples of adolescents aged 13 to 18 (N=10123) in the 
continental United States. The interviews were also conducted by trained lay interviewers. 
Diagnoses were made according to the DSM-IV based on WHO modified CIDI interviews 
(39). 
Unipolar mania was defined as the presence of at least one manic episode without a history 
of a major depressive episode over the lifetime. 
Approval of the study protocols were granted by the respective ethical review boards of 
participating centers and all participants gave written informed consent prior to participation. 
 
2.2. Statistics  
The data of the 7 adult studies and those of the 2 adolescent studies were pooled in order to 
conduct separate analyses in adults and adolescents. Participants with unipolar mania and 
BP-I disorder were compared using Generalized Linear Mixed Models (GLMM) with 
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adjustment for sex and age as well as for each study source as a random effect. The 
introduction of the random effect in the analyses could remedy potential heterogeneity across 
samples. A GLMM explains the relation between the predictors and the response variable via 
a link function. For dichotomous outcome variables, we chose the logit link function; for 
continuous outcome variables, we chose the identity function, which results in ordinary 
Linear Mixed Models. The models with sex and age as outcome variables were only adjusted 
for age or sex, respectively, and for the study effect. Aside from age and sex, the outcome 
variables comprised age of onset of mania, comorbid conditions (suicide attempts, 
GAD/panic disorder, bulimia/binge eating and sedative, drug and alcohol use disorders), 
hyperthymic and anxious temperament (in adults) as well as psychiatric family history 
variables (mania, depression, suicide attempts, anxiety/panic, bulimia/binge eating, any 
substance use disorder and alcohol use disorders). These analyses were performed using 
the stats package of R language for statistical computing: URL https://www.R-project.org/.  
 
3. Results 
3.1. Mania vs. BP-I disorder in the seven adult studies  
Table 1 presents the lifetime prevalence rates, gender distribution, age, age at onset of the 
first manic episode and the proportion of subjects with the six comorbid mental conditions in 
the seven adult samples. In total, 109 cases of unipolar mania versus 323 cases of bipolar-I 
disorder could be compared. The subsamples varied greatly in size.  
The lifetime prevalence of unipolar mania was about a third that of BP-I disorder, except in 
the two studies from Zurich (Zurich Study and ZInEP Study), where the two disorders had 
similar prevalence rates. Moreover, the Zurich Study and the Pelotas Study identified a much 
higher prevalence for both unipolar mania and BP-I disorder than the other surveys. The 
prevalence estimate of the NESDA Study could not be compared with those of the other 
studies because of the enrichment of the sample with individuals with depression. 
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In the pooled sample, the gender distribution of adults with mania compared to those with 
BP-I disorder differed significantly according to the generalized linear mixed model with 
adjustment for age and the effect of the study source. Indeed, men were preponderant in the 
group with unipolar mania compared to the BP-I group, a finding consistent to varying 
degrees across the individual studies, the exception being the NCS-R study, where the 
distribution was about equal. In contrast, individuals with unipolar mania did not differ from 
those with BP-I disorder regarding age or the age at onset of the first manic episode.  
Regarding comorbid conditions, the proportion of subjects with suicide attempts, GAD/panic, 
eating and drug use disorders was significantly lower in the group with unipolar mania than in 
the BP-I group. 
- insert table 1 - 
Table 2 shows the proportion of subjects with mania vs. BP-I regarding temperamental traits 
and a family history of seven mental disorders in the adult studies. There were no differences 
between the two groups regarding hyperthymic temperament, assessed in two studies 
(Zurich and PsyCoLaus), or anxious temperament, for which data was available from the 
Zurich and São Paolo studies. Similarly, there were no inter-group differences regarding the 
family history of the mental disorders assessed in the pooled analyses. 
- insert table 2 - 
3.2. Mania vs. BP-I disorder in the two adolescent studies  
Table 3 displays the gender distribution, age, age at onset of the first manic episode and the 
proportion of subjects with comorbid conditions among individuals with unipolar mania and 
with bipolar-I disorder in the two adolescent studies. In total, there were 195 cases with 
unipolar mania and 182 with bipolar-I disorder. In the EDSP study, BP-I disorder was more 
prevalent than unipolar mania, whereas in the NCS-A the converse was true. As in the adult 
subsample, there were more males in the adolescent groups with unipolar mania than in the 
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BP-I groups, whereas the two groups did not differ regarding age or age at onset of mania. 
Both suicide attempts and GAD/panic disorder were significantly more common among the 
adolescents with BP-I disorder than among those with mania. 
- insert table 3 - 
As shown in Table 4, in the adolescent studies there were no significant differences between 
the two diagnostic groups in terms of the family history of the mental disorders assessed. 
Data on temperamental traits were not available for the two adolescent studies. 
- insert table 4 - 
4. Discussion 
This paper presents the first broadly based multisite analysis of nine well-known community 
studies from five countries comparing the clinical and demographic characteristics of 
subjects with unipolar mania and bipolar-I disorder. We found significant differences in the 
gender ratio and patterns of comorbidity between unipolar mania and BP-I disorder, which 
may index important differences in the underlying risk factors and etiology of these 
conditions. Our paper extends an earlier review which was based mainly on clinical samples 
(9) to data from the community including also two studies on adolescents. This previous 
review supported the distinction between unipolar mania and bipolar disorder as subtypes of 
the affective spectrum.  
The pooling of our epidemiological data involved issues of comparability, arising not only 
from differences between interviews, their methods of administration and diagnostic 
classification systems (ICD vs. DSM) but also from cultural variations. In this respect it is 
remarkable that two studies, the Zurich study and the Pelotas studies, established higher 
prevalence of both unipolar mania and BP-I. Regarding the Zurich study, the higher 
prevalence estimates of these disorders are likely to be attributable to the longitudinal 
approach with 7 interviews over more than 30 years, the use of a diagnostic interview with a 
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lower threshold to enter the mania section as compared to the diagnostic tools at the other 
sites and potentially an increased awareness of the team in identifying manic/hypomanic 
episodes compared to in the other centers. Nevertheless, despite methodological variance 
the age differences of the participants and the gender distribution between unipolar mania 
and BP-I disorder was similar across the studies. Gender is an interesting validator; the 
combined results of all our studies showed a clear preponderance of women with BP-I 
disorder and a preponderance of men with unipolar mania. This corroborates Baek et al.'s 
findings from the NESARC community study using a narrowly defined group (with at least 3 
episodes and 10 years illness duration) of 76 subjects diagnosed with unipolar mania (M/Md) 
and 935 with bipolar disorders (18). However, Rajkumar's recent clinical study (13) failed to 
find any significant gender difference between the diagnoses, despite there being a higher 
percentage of women in the group with unipolar mania than in the BP-I group. It should be 
borne in mind, however, that 38 of the 66 patients in that study were diagnosed with unipolar 
mania (57%) and only 28 (43%) with BP-I disorder, an unusual distribution not often 
reported. A review of the literature on clinical cases by Yazici et al. (8) mentioned 
contradictory findings with regard to gender distribution and also stressed culture as a 
potentially influential variable. In this connection, Douki et al. (40) found unipolar mania to be 
three times more common among patients in Tunisia than in France. These high rates in 
Tunisia were recently confirmed by Amamou et al.(11). Both Douki et al. and Amamou et al. 
attributed these differences to cultural variations and seasonality. Cultural differences in the 
awareness and experience of depressive and manic symptoms represent a significant 
limitation of studies on affective disorders.  
Our finding that unipolar mania in both adults and adolescents is significantly less strongly 
associated than BP-I disorder with GAD and panic disorders confirms the results of 
Merikangas et al. in adolescents (41) and of Baek et al. in adults (18). It also corroborates 
three earlier reviews of clinical studies (10, 42, 43) and the clinical studies of Andrade et al. 
(44) and of Grobler et al.(12).  
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The lower risk of suicide attempts among adults and adolescents with unipolar mania 
compared to those with BP-I disorder in our study is a striking and clinically relevant finding. 
Indeed, suicide attempts in all seven adult surveys showed the same trend and overall were 
half as frequent among those with unipolar mania as among those with BP-I disorder (19.3% 
vs 38.3%). This difference was even more pronounced in the two adolescent studies (5.6% 
vs. 22.0%). This is in agreement with a long-term follow-up study of a sample of hospital 
admissions in Zurich (45), with the study of Grobler et al. (12) , with the reviews of Yazici (8) 
and Mehta (10) as well as with the recent finding of Amamou et al. in Tunisia (11). Our 
observation of a lower proportion of bulimia/binge eating disorders among adults with 
unipolar mania than among those with BP-I disorder is a new finding. Indeed, to our 
knowledge the rate of eating disorders has not yet been studied among unipolar manic 
subjects and could have important implications in terms of an attenuated likelihood of 
developing metabolic complications as compared to typical BP-I patients.      
Our finding that the proportion of drug use disorders is lower among adults with unipolar 
mania than among those with BP-I disorder conflicts with the study of Grobler et al.(12), who 
found more cannabis abuse among patients with unipolar mania only than in those with 
mania and depression. The clinical evidence of differences in the history of substance 
misuse among patients with unipolar mania and with bipolar disorder is mixed. In line with 
our findings, at least two earlier studies documented higher levels of substance abuse in 
those with bipolar disorder (46), (47), whereas another reported no difference (44) and yet 
another observed more cannabis and amphetamine use in the group with unipolar mania 
(48). These inconsistent findings may derive from the varying severity of unipolar mania in 
the different studies. It has been shown, for instance, that more severe cases of unipolar 
mania with more psychotic features are more prone to substance abuse (12, 48). Our 
analysis shows that subjects with unipolar mania are less affected overall by comorbid 
conditions than those with BP-I disorder although we could not test for the severity of manic 
episodes in terms of psychotic features. Indeed, the lower degree of severity with a lower 
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occurrence of psychotic features in our community samples as compared to clinical studies 
generally diminished our ability to assess differences in severity between unipolar mania and 
BP-I disorder. We hypothesize that the higher risk of anxiety, eating and drug use disorders 
as well as suicidality in BP-I disorder compared to in unipolar mania is predominantly linked 
to the depressive component of the former disorder. 
Two clinical studies (15, 49) found that patients with unipolar mania more rarely reported a 
positive family history of major depressive disorder than those with bipolar disorder. This 
finding was corroborated by the data from the NESARC study (18) but was not confirmed in 
our analyses controlled for age and gender. Indeed, as in some other studies that assessed 
family history (8, 12), none of these variables reached the level of statistical significance in 
our adjusted analyses. It has been shown that family history reports are subject to multiple 
bias (32), which could have led to an underestimation of associations between the patient's 
diagnostic status and disorders in relatives. Hence, our results based on family history 
reports need confirmation by family studies, which rely on direct interviews of relatives. 
Limitations: First, given that unipolar mania is a rare disorder in the community, the sample 
sizes of several of the adult studies included were small. Second, the studies included in our 
analyses revealed considerable methodological heterogeneity. As not all datasets comprised 
exactly the same variables, comparisons were sometimes made between similar but not 
identical comorbid conditions or family histories of psychiatric syndromes. For instance, 
some disorders were assessed together (e.g. GAD and / or panic disorder, or bulimia and / 
or binge eating) because of strong longitudinal overlap and small Ns. Although we adjusted 
for the study source in our analyses, methodological variance across studies bears the risk of 
non-differential (conservative) bias, resulting in an underestimation of the size of 
associations, i.e. owing to this bias we may have failed to detect more differences between 
unipolar mania and BP-I disorder. Third, several clinical course characteristics were not 
assessed in the majority of studies which limited our ability to test meaningful course 
differences between unipolar mania and BP-I disorder. Ultimately, future studies should 
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assess differences in course and treatment outcomes between unipolar mania and BP-I 
disorder.   
Fourth, there is the likelihood of misclassification bias, as an undefined number of 
respondents with unipolar mania may present with a depressive episode later on in life. This 
applies especially to adolescents who may still develop major depressive episodes or even 
associated comorbid conditions at a later age. Such misclassification may have reduced the 
ability to distinguish specific features or comorbid conditions associated with unipolar mania. 
The NESARC study found the presence of GAD or ADHD to predict an increased transition 
from unipolar mania to bipolar disorder over a 3-year follow-up. This was however not the 
case for subthreshold depression (18). Fifth, it cannot be ruled out that there could have 
been symptom overlap among some of the conditions, such as anxiety symptoms or suicide 
attempts actually being more part of the depressive episodes of bipolar disorder per se.  
Despite these limitations, our analysis of the pooled data from nine well-known 
epidemiological surveys shows that for two important validators: gender and comorbidity of 
mental conditions, there are considerable differences between individuals with unipolar 
mania and those with bipolar-I disorder. These differences suggest that the diagnostic 
distinction between the two disorders should be made both for research and clinical 
purposes, and that their merger in DSM-5 and ICD-10 should be viewed with caution as 
previously shown by the NESARC study (18). In research settings, the lumping together of 
the two disorders is likely to lead to the creation of a more heterogeneous category of bipolar 
disorder, which may hamper efforts to determine etiology. In clinical settings, the treatment 
and prevention of unipolar mania – in less severe cases at least – is potentially less complex 
than that of bipolar-I disorder from a pharmacological point of view, given the absence of 
depressive episodes. Indeed, in unipolar mania, prevention only needs to focus on mania, 
whereas in bipolar disorders, prevention of both manic and depressive episodes may be 
more difficult to achieve and frequently needs the association of more than one drug (50). 
Nevertheless, the particular aspects of acute and maintenance pharmacological treatment for 
17 
unipolar mania should still be better defined. Moreover, our results suggest that the rarer 
occurrence of suicide attempts, anxiety and drug use disorders among individuals with 
unipolar mania may facilitate the successful treatment of manic episodes and lead to a more 
favorable course of the disorder. In contrast, the diagnosis of bipolar-I disorder, with both 
manic and depressive episodes, should alert the clinician to the risk of suicide attempts and 
favor the detection and treatment of possible comorbid anxiety, eating and drug use 
disorders in order to improve the long-term course of this complex disorder. 
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Table 1: Seven adult studies: prevalence, characteristics and comorbidity across diagnostic groups – unipolar mania (M) vs BP-I 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
° adjusted for sex and age as fixed effects and study source as random effect. (Sex and age variables were only adjusted for the alternate variable and for study source). 
§ weighted prevalence estimate. 
 
Study (N) Total 
Zurich 
(n=591) 
ZINEP 
(n=1500) 
São Paulo 
(n=5037) 
Pelotas 
(n=1560) 
NCS-R 
(n=5692) 
PsyCoLaus 
(4874) 
NESDA 
(n=2596) 
 
Generalized linear 
mixed models 
Diagnosis M BP-I M BP-I M BP-I M BP-I M BP-I M BP-I M BP-I M BP-I 
OR or β 
(95% CI)° 
p 
Prevalence % 3.1§ 2.7§ 0.21§ 0.19§ 0.21§ 0.64§ 2.37 5.13 0.32§ 0.66§ 0.18 0.74 - - - -   
N 18 19 4 7 6 29 37 80 33 68 9 36 2 84 109 323   
Males (n) 
% 
(9) 
50.0 
(8) 
42.1 
(2) 
50.0 
(3) 
42.9 
(4) 
66.7 
(13) 
44.8 
(18) 
48.7 
(24) 
30.0 
(13) 
39.4 
(25) 
36.8 
(9) 
100 
(20) 
55.7 
(2) 
100 
(36) 
42.9 
(57) 
52.3 
(129) 
39.9 
1.78 
(1.15; 2.81) 
<.05 
Age: mean 49.5a 49.6a 27.8 24.7 32.7 40 20.3 20.2 33.5 37 50.7 52.3 50.5 40.7 33.1 36.3 
-1.52 
(-3.7; 0.66) 
n.s. 
Onset mania: median 23.2 16.1 26.8 22.9 20.7 28.5 - - - - 30.9 37.1 41.5 24.8 25.9 26.8 
1.77 
(-2.53; 6.07) 
n.s. 
Lifetime comorbidity of mental conditions (n) % 
Suicide attempts  
(2) 
11.1 
(3) 
15.8 
(0) 
0 
(2) 
28.6 
(0) 
0 
(8) 
27.6 
(15)b 
40.5 
(39)b 
48.8 
(3) 
9.1 
(31) 
45.6 
(1) 
11.1 
(12) 
35.3 
(0) 
0 
(28) 
33.3 
(21) 
19.3 
(123) 
38.3 
0.38 
(0.22; 0.65) 
<.001 
GAD/Panic 
(7) 
38.9 
(11) 
57.9 
(2) 
50 
(2) 
28.6 
(1) 
16.7 
(14) 
48.3 
(17) 
46.0 
(39) 
48.8 
(17) 
51.5 
(57) 
83.8 
(0) 
0 
(6) 
18.2 
(0) 
0 
(63) 
75 
(44) 
40.4 
(192) 
60 
0.46  
(0.28; 0.75) 
<.01 
Bulimia/Binge eating 
(2) 
11.1 
(7) 
36.8 
- - 
(0) 
0 
(12) 
41.4 
(2)c 
5.4 
(6)c 
7.5 
(3) 
9.1 
(9) 
13.2 
(0) 
0 
(2) 
6.1 
- - 
(7) 
6.5 
(36) 
15.3 
0.38  
(0.16; 0.90) 
<.05 
Sedative  ab/dep 
(4) 
22.2 
(4) 
21.1 
- - 
(1) 
16.7 
(7) 
24.1 
(1) 
2.7 
(10) 
12.5 
(2) 
6.1 
(9) 
13.2 
(0) 
0 
(0) 
0 
- - 
(8) 
7.8 
(30) 
13.0 
0.53 
(0.24; 1.18) 
n.s. 
Drug  ab/dep 
(2) 
11.1 
(7) 
36.8 
(1) 
25 
(1) 
14.3 
(3) 
50.0 
(7) 
24.1 
(6) 
16.2 
(23) 
28.8 
(11) 
33.3 
(37) 
54.4 
(1) 
11.1 
(3) 
8.6 
- - 
(24) 
22.4 
(78) 
32.8 
0.50 
(0.29; 0.87) 
<.05 
Alcohol  ab/dep 
(6) 
33.3 
(8) 
42.1 
(1) 
25.0 
(1) 
14.3 
(4) 
66.7 
(12) 
41.4 
(14) 
37.8 
(27) 
33.8 
(18) 
54.6 
(38) 
55.9 
(3) 
33.3 
(10) 
28.6 
(1) 
50 
(15) 
18.1 
(47) 
43.1 
(111) 
34.6 
1.05 
(0.66; 1.69) 
n.s. 
22 
a age in 2008 (at the 7th follow-up assessment). 
b includes attempts as well as suicide ideation. 
c includes only current bulimia. 
GAD = generalized anxiety disorder; ab/dep = abuse/dependence. 
-:  no data available for these variables. 
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Table 2: Seven adult studies: temperamental traits and family history of mental disorders – unipolar mania (M) vs BP-I 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
° adjusted for sex and age as fixed effects and study source as a random effect.   
a family history information was only available for subjects who entered the chapter investigating the given disorder. 
b 13 subjects with missing information on family history. 
 
Study Total 
Zurich ZINEP São  Paulo Pelotas NCS-R PsyCoLaus NESDA  
Generalized linear 
mixed models 
Diagnosis M BP-I M BP-I M BP-I M BP-I M BP-I M BP-I M BP-I M BP-I OR(95% CI)° p 
N 18 19 4 7 6 29 37 80 33 68 9 36 2 84 109 323   
Temperament (N) 
% 
Hyperthymic 
(14) 
77.8 
(14) 
73.7 
- - - - - - - - 
(3) 
33.3 
(2) 
5.6 
- - 
(17) 
63.0 
(16) 
29.1 
2.37 
(0.75; 7.51) 
n.s. 
Anxious 
(1) 
5.6 
(4) 
21.1 
- - 
(0) 
0 
(13) 
44.8 
- - - - - - - - 
(1) 
4.2 
(17) 
35.4 
0.08 
(0.0; 0.96) 
n.s. 
Family history (N) 
% 
Mania 
(4) 
22.2 
(4) 
21.1 
(0) 
0 
(1) 
14.3 
(4) 
66.7 
(15) 
51.7 
- - 
(15)a   
57.7 
(45)a 
70.3 
(0)b 
0 
(3)b 
12.0 
- - 
(23) 
37.7 
(68) 
47.2 
0.74 
(0.37; 1.48) 
n.s. 
Depression 
(10) 
55.6 
(13) 
68.4 
(3) 
100 
(4) 
57.1 
(3) 
50 
(19) 
65.5 
- - 
(5)c 
21.7 
(20)c 
36.4 
(6)b 
85.7 
(17)b 
68.0 
(2) 
100 
(71) 
85.5 
(29) 
49.2 
(144) 
66.1 
0.79 
(0.42; 1.52) 
n.s. 
Suicide attempts  
(5) 
27.8 
(8) 
42.1 
(1) 
25 
(1) 
14.3 
(2) 
33.3 
(6) 
20.7 
(2) 
7.1 
(13) 
18.8 
(2)c 
10 
(8)c 
15.7 
(1)b 
14.3 
(4)b 
16.0 
- - 
(13) 
15.7 
(40) 
20 
0.76 
(0.38; 1.52) 
n.s. 
Anxiety/Panic 
(8)d 
44.4 
(10)d 
52.6 
(3)d 
75 
(3)d 
42.9 
(1)d 
16.7 
(13)d 
44.8 
- - 
14a,d 
93.3 
47 a,d 
90.4 
(0)b,e 
0 
(5)b,e 
20.0 
(1)e 
50 
(60)e 
72.3 
(27) 
51.9 
(138) 
64.2 
0.70  
(0.33; 1.48) 
n.s. 
Bulimia/Binge eating 
(9) 
50 
(7) 
36.8 
(1) 
25 
(2) 
28.6 
(2) 
33.3 
(6) 
20.7 
- - - - - - - - 
(12) 
42.9 
(15) 
27.3 
2.05 
(0.77; 5.44) 
n.s. 
Any substance ab/dep 
(1) 
5.9 
(5) 
26.3 
(2) 
50 
(2) 
28.6 
(3) 
50 
(8) 
27.6 
- - 
(16)a 
84.2 
(38)a 
90.5 
(4)b 
57.1 
(7)b 
28.0 
(1) 
50 
(38) 
45.8 
(27) 
49.1 
(98) 
47.8 
1.21 
(0.56; 2.61) 
n.s. 
Alcohol  ab/dep 
(1) 
5.9 
(5) 
26.3 
(2) 
50 
(2) 
28.6 
- - - - - - 
(4)b 
57.1 
(7)b 
28.0 
(1) 
50 
(34) 
41 
(8) 
26.7 
(48) 
35.8 
0.89 
(0.34; 2.32) 
n.s. 
24 
c family history information was only available on the parents of subjects who entered the childhood section. 
d includes family history of GAD and panic disorder. 
e includes any anxiety disorder / complaint. 
GAD = generalized anxiety disorder; ab/dep = abuse/dependence. 
-:  no data available for these variables. 
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Table 3: Two adolescent studies: prevalence, characteristics and comorbidity – unipolar mania (M) vs BP-I 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
° adjusted for sex and age as fixed effects and study source as random effect. (Sex and age variables were only adjusted for the alternate variable and for study source). 
§ weighted prevalence estimate. 
a age at the 3rd follow-up assessment. 
 
Study Total 
EDSP 
(n=3021) 
NCS-A 
(n=10123) 
 
Generalized linear 
mixed models 
Diagnosis M BP-I M BP-I M BP-I 
OR or β 
(95% CI)° 
p 
Prevalence % 1.02§ 1.74§ 1.71§ 1.08§ - - - - 
N 33 51 162 131 195 182   
Males (n) 
% 
(21) 
63.6 
(21) 
41.2 
(89) 
54.9 
(43) 
32.8 
(110) 
56.4 
(64) 
35.2 
2.51 
(1.64; 3.82) 
<.0001 
Age: mean 24.9a 25.6a 15.4 15.5 17.0 18.3 
-0.24 
(-0-78; 0.30) 
n.s. 
Onset mania: median 14.7 15.8 - - 14.7 15.8 
0.92 
(-0.99; 2.83)  
n.s. 
Comorbidity of mental conditions (n) 
% 
Suicide attempts  
(3) 
9.1 
(14) 
27.5 
(8)  
4.9 
(26) 
19.9 
(11) 
5.6 
(40) 
22.0 
0.25 
(0.12; 0.51) 
<.001 
GAD/Panic 
(6) 
18.2 
(21) 
41.2 
(65) 
40.1 
(81) 
61.8 
(71) 
36.4 
(102) 
56.0 
0.43 
(0.28; 0.66) 
<.001 
Bulimia/Binge eating 
(0) 
0 
(2) 
3.9 
(18) 
11.1 
(25) 
19.1 
(18) 
9.2 
(27) 
14.8 
0.61 
(0.32; 1.17) 
n.s. 
Sedative  ab/dep 
(0) 
0 
(0) 
0 
- - 
(0) 
0 
(0) 
0 
- - 
Drug  ab/dep 
(14) 
42.4 
(14) 
27.5 
(34) 
21.0 
(43) 
32.8 
(48) 
24.6 
(57) 
31.3 
0.67 
(0.42; 1.08) 
n.s. 
Alcohol  ab/dep 
(25) 
75.8 
(22) 
43.1 
(30) 
18.5 
(30) 
22.9 
(55) 
28.2 
(52) 
28.6 
1.08 
(0.66; 1.77) 
n.s. 
26 
GAD = generalized anxiety disorder; ab/dep = abuse/dependence. 
-:  no data available for these variables. 
27 
Table 4: Two adolescent studies: family history of unipolar mania (M) vs. BP-I  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Study Total 
EDSP NCS-A  
Generalized linear 
mixed models 
Diagnosis M BP-I M BP-I M BP-I 
OR  
(95% CI)° 
p 
N 33 51 162 131 195 182   
Family history (N) 
% 
Mania 
(2) 
6.1 
(4) 
7.8 
(93)a 
71 
(86)a 
75.4 
(95) 
57.9 
(90) 
54.6 
0.77 
(0.45; 
1.33) 
n.s. 
Depression 
(14) 
42.4 
(29) 
56.9 
(9)a 
81.8 
(90)a 
84.1 
(23) 
52.3 
(119) 
75.3 
0.53 
(0.25; 
1.13) 
n.s. 
Suicide attempts  - - 
(4)b 
2.8 
(11)b 
9.3 
(4) 
2.8 
(11) 
9.3 
0.35 
(0.10; 
1.22) 
n.s. 
Anxiety/Panic 
(7)c,d 
21.2 
(15)c,d 
29.4 
(48)a,c 
98 
(68)a,c 
95.6 
(55) 
67.1 
(80) 
67.2 
0.82 
(0.33; 2.0) 
n.s. 
Any substance ab/dep 
(20) 
60.6 
(25) 
49.0 
(41)a 
87.2 
(46)a 
80.7 
(61) 
76.3 
(71) 
65.7 
1.58 
(0.79; 
3.18) 
n.s. 
Alcohol  ab/dep 
(12) 
36.4 
(13) 
25.5 
- - 
(12) 
36.4 
(13) 
25.5 
1.85 
(0.69; 5.0) 
n.s. 
28 
° adjusted for sex and age as fixed effects and study source as random effect. 
a family history information was only available for subjects who entered the chapter investigating the given disorder. 
b family history information was only available on the parents of subjects who entered the childhood section. 
c includes family history of GAD and panic disorder. 
d includes information on mothers and fathers for GAD and / or panic disorder. 
GAD = generalized anxiety disorder; ab/dep = abuse/dependence. 
- :  no data available for these variables. 
 
